Six-year-old Bentley’s diagnosis of precursor B cell acute lymphocytic leukemia (B-ALL) in 2019 sent his family into a tailspin of worry about what the future would hold for the sweet boy who loved to make everyone laugh.

It didn’t take long for the family’s anxiety to turn cautiously toward hope. Bentley was enrolled in a University of Oklahoma Health Sciences clinical trial studying whether a drug called blinatumomab, when given in conjunction with chemotherapy, would improve patients’ survival without the cancer returning. Within a month, Bentley’s leukemia was in remission, and he remains disease-free today.

Physicians at the University of Oklahoma Health Sciences in Oklahoma City are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant.

On Friday, the University of Oklahoma College of Allied Health celebrated the opening of its new Interprofessional Sonography Laboratory, an advanced learning space made possible through a 10-year Value Partnership with global medical technology company Siemens Healthineers and through funding from the Presbyterian Health Foundation in Oklahoma City.

University of Oklahoma Health Sciences Fran and Earl Ziegler College of Nursing has partnered with New York University Rory Meyers College of Nursing and the George Kaiser Family Foundation to explore strategies to decrease maternal and infant mortality through education and support. The coalition recently brought together various stakeholders at OU-Tulsa to discuss a successful and sustainable pathway to explore nurse-midwifery education and practice as one mechanism to address maternal and infant mortality in Oklahoma.

Research published Nov. 21 in the prestigious New England Journal of Medicine demonstrates a three-fold reduction in a risky repeat surgery for patients with subdural hematoma, a pooling of blood between the skull and the surface of the brain. The reduced risk was shown in patients whose hematoma was removed through traditional neurosurgery and who also underwent a less invasive procedure known as embolization to block the artery supplying blood to the hematoma. The University of Oklahoma College of Medicine was one of 39 academic health institutions across the United States that enrolled patients in the EMBOLISE clinical trial.